Why is InspireMD, Inc. ?
- NET PROFIT(HY) Higher at USD -25.45 MM
- NET SALES(Q) Highest at USD 3.4 MM
- RAW MATERIAL COST(Y) Fallen by -6.19% (YoY)
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -70.66%, its profits have fallen by -52.4%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Along with generating -70.66% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to InspireMD, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is InspireMD, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Higher at USD -25.45 MM
Highest at USD 3.4 MM
Fallen by -6.19% (YoY
Highest at USD 95.78 MM
Highest at 2.66 times
Highest at 4.23 times
Lowest at USD -38.65 MM
Lowest at -142.6%
Lowest at USD -13.83 MM
Lowest at USD -13.69 MM
Lowest at USD -13.69 MM
Here's what is working for InspireMD, Inc.
Net Sales (USD MM)
Net Sales (USD MM)
Cash and Cash Equivalents
Inventory Turnover Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for InspireMD, Inc.
Operating Cash Flows (USD MM)
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)






